boehringer ingelheim glp-1 invests $30 million into antibody drug conjugate research and development glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement | Boehringer Ingelheim
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



























